For type 2 diabetes, your options include: DPP-4 inhibitors GLP-1 receptor agonists (Ozempic, Trulicity, Victoza) GLP-1/GIP receptor agonists (Mounjaro) SGLT2 inhibitors Thiazolidinediones And prescription weight-loss medications that are currently available include: Orforglipron, an oral small-molecule non-peptide GLP-1 receptor agonist ( Foundayo ) GLP-1/GIP receptor agonists ( Zepbound ) Phentermine-topiramate ( Qsymia ) Bupropion-naltrexone ( Contrave ) Your clinician, like those through Weight Watchers Med+ , can go over your available options and, if you qualify, prescribe medication and a lifestyle plan designed for your body and your goals.* Retatrutide warnings and precautions Despite the fact that retatrutide is not an approved medication, there is active marketing for medications being characterized as retatrutide. Because retatrutide is still investigational, there is no regulated manufacturing or supply chain, meaning you cannot be sure what you are actually receiving and putting in your body, says Rhodes
CKD: chronic kidney disease
The commercial success of any weight loss therapeutic will depend heavily on patient acceptability and adherence, making oral, long-acting depot, and other non-injectable options critical pipeline priorities rather than nice-to-have features
FAQ How long does nausea last when starting GLP-1 medications
NASH field celebrates hurrah moment with a first FDA drug approval for the liver disease
/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
